Introduction {#section1-0269881114532858}
============

Inhalation of air enriched with 7.5% carbon dioxide (CO~2~) produces reliable increases in subjective anxiety and autonomic arousal (e.g. blood pressure and heart rate (HR)) in healthy humans ([@bibr1-0269881114532858]). The subjective effects of 7.5% CO~2~ challenge are well characterised, and include increased anxiety, nervousness, worry, fearful apprehension and tension ([@bibr1-0269881114532858]). These feelings are quantitatively and qualitatively less pronounced than the sudden acute feelings of panic (overwhelming intense fear and discomfort) that accompany the single vital capacity inhalation of 35% CO~2~ ([@bibr7-0269881114532858]). Accordingly, there is growing consensus that 7.5% CO~2~ challenge provides an experimental model of anxiety that complements, but differs from the 35% CO~2~ model of panic.

Recent research has examined whether 7.5% CO~2~ challenge can induce biases in cognition and emotion processing that promote the feelings of worry, nervous apprehension and perceptions of threat that characterise anxiety. For example, 7.5% CO~2~ challenge increases attention (erroneous eye-movements) to threatening aversive, visual stimuli in an antisaccade task ([@bibr20-0269881114532858]) and increases hypervigilance through enhancing alerting (temporal) and orienting (spatial) attention network function ([@bibr18-0269881114532858]). Similarly, studies in rodents show that exposure to 10% CO~2~ increases behavioural inhibition, freezing and reduced activity in an open-field test ([@bibr54-0269881114532858]). Thus, across species, inhalation of low concentrations of CO~2~ appears to trigger a range of behavioural responses characteristic of the anxiety phenotype.

Adaptive responses to threat can be considered across a defence cascade. An anxious preparatory state is characterised by vigilance, alertness, behavioural inhibition and appraisal, and enables the organism to monitor the risk associated with an anticipated, distal, often uncircumscribed threat. In contrast, active defence and avoidance (fight-flight) characterise an acute fear state that is mobilised by an identified, localized and proximal threat (for extended discussion of fear versus anxiety in humans and rodents see [@bibr3-0269881114532858]; [@bibr32-0269881114532858]; [@bibr33-0269881114532858]).

One of the most reliable components of human defence is the eye-blink reflex, a rapid and intense contraction of the orbicularis muscle in response to a startling stimulus (typically a loud noise). This defensive reflex is greater (potentiated) in threatening contexts (e.g. when the delivery of an aversive shock is unpredictable; [@bibr24-0269881114532858]; [@bibr22-0269881114532858]), and when viewing aversive pictures ([@bibr46-0269881114532858]; [@bibr50-0269881114532858]). Conversely, the startle response is reduced to positive/appetitive stimuli (e.g. [@bibr50-0269881114532858]). Startle responses are greater in fearful individuals (e.g. when phobic individuals view fear-provoking stimuli; [@bibr27-0269881114532858]) and also in several anxious populations (see [@bibr49-0269881114532858] for a review) such as with post-traumatic stress disorder (PTSD) (e.g. [@bibr37-0269881114532858]) and panic disorder (e.g. [@bibr36-0269881114532858]). Comparatively few studies have examined the affective modulation of startle latency, however there is evidence that startle responses are quicker to aversive, relative to positive stimuli ([@bibr38-0269881114532858]; [@bibr53-0269881114532858]), and to stimuli that elicit high, relative to low levels of arousal ([@bibr8-0269881114532858]; [@bibr28-0269881114532858]; [@bibr53-0269881114532858]).

Research in rodents ([@bibr29-0269881114532858], [@bibr30-0269881114532858]; [@bibr43-0269881114532858]), human imaging ([@bibr41-0269881114532858]) and human lesion studies ([@bibr5-0269881114532858]; [@bibr15-0269881114532858]) implicate the extended amygdala, and in particular the central nucleus of the amygdala and the bed nucleus of the stria terminalis (BNST), in mediating startle potentiation. Lesion studies suggest that the central nucleus of the amygdala potentiates startle responses to brief, short-duration fear-provoking aversive stimuli (i.e. it mediates fear-potentiated startle). Conversely, the BNST does not potentiate startle to discrete aversive cues, but does potentiate startle over sustained periods of anxiety (for example, when nocturnal rodents are exposed to bright light or when humans anticipate prolonged uncertain threat; see [@bibr21-0269881114532858] for a review). Likewise, the central role of the extended amygdala in normal fear and pathological anxiety is well characterised ([@bibr10-0269881114532858]; [@bibr11-0269881114532858]). Furthermore, recent evidence in rodents suggests the amygdala functions as an important chemosensor that directly detects increases in CO~2~ (via acid-sensing ion channels (ASIC1a)), to increase behavioural inhibition and freezing in rodents ([@bibr54-0269881114532858]).

While inhalation of low concentrations of CO~2~ increases anxiety and autonomic arousal in humans ([@bibr1-0269881114532858]), and triggers anxious behaviour in both small animals ([@bibr54-0269881114532858]) and humans ([@bibr17-0269881114532858], [@bibr18-0269881114532858]), its effects on the defensive behaviours that are mediated by the extended amygdala are not known. To date, only two studies have explored the effects of CO~2~ challenge on the human eye-blink startle response ([@bibr6-0269881114532858]; [@bibr39-0269881114532858]). Both studies examined the magnitude (but not latency) of three startle responses to acoustic probes delivered during a short (\< 2 min) inhalation of 7.5% CO~2~. Contrary to predictions, startle magnitudes were reduced (rather than potentiated) during CO~2~ challenge, relative to baseline. These findings contrast with evidence that 7.5% CO~2~ challenge over longer durations (10--20 minutes) can *increase* anxious behaviour in response to threat in both humans and animals.

We compared the effects of 7.5% CO~2~ versus air inhalation on eye-blink startle reactivity to threatening (aversive) and non-threatening (neutral) picture stimuli. An optimal adaptive startle response to threat should be both robust and quick. Our study is the first to examine the effect of 7.5% CO~2~ challenge on both startle magnitude and startle latency. We predicted that if 7.5% CO~2~ inhalation triggers defensive behaviour coordinated by the amygdala, then eye-blink startles would be larger and faster during CO~2~, and particularly in response to aversive images.

Methods {#section2-0269881114532858}
=======

Ethical considerations {#section3-0269881114532858}
----------------------

This study was approved by the University of Southampton Ethics and Research Governance Committee in the UK. All participants provided written informed consent prior to participation.

Research participants {#section4-0269881114532858}
---------------------

Our study was completed by 27 participants (16 female) aged 18--26 years old (mean age = 20.62, standard deviation (SD) = 2.14). Participants completed a health screen by telephone and a pre-test screening interview in order to confirm their eligibility. Exclusion criteria included: current or history of psychiatric illness as assessed by the MINI International Neuropsychiatric Interview (based on DSM-IV; [@bibr45-0269881114532858]), personal or family history of panic disorder or panic attacks, medication use within the last 8 weeks (apart from local treatment, occasional aspirin or paracetamol, and contraceptives), smoking, history of asthma/respiratory disease, diabetes, migraines, cardiovascular disease, excessive alcohol consumption (this was set at \> 50 units/week for males or \> 35 units/week for females; the mean intake across eligible participants was 9.4 units/week, SD = 6.9) or a positive alcohol breath test, current or past alcohol or drug dependence (including recent recreational drug use), being under- or over-weight (body mass index (BMI) \< 18 or \> 28kg/m^2^), blood pressure exceeding 140/90 mmHg or a HR of \< 50 bpm or \> 90 bpm, caffeine consumption of \> 8 caffeinated drinks/day, or pregnancy/breastfeeding. Levels of trait anxiety (trait version of the State--Trait Anxiety Inventory ([@bibr47-0269881114532858]); mean = 32.10, SD = 6.67) were comparable with those observed in healthy control groups ([@bibr19-0269881114532858]).

Procedure {#section5-0269881114532858}
---------

Participants attended a single test session and completed an affective startle task twice: once during a 20-minute inhalation of air enriched with 7.5% CO~2~ (a balance of 7.5% CO~2~, 21% O~2~ and 71.5% N~2~) and once during a 20-minute inhalation of normal air. Inhalations were administered blind to participants and were separated by a 30-minute break to remove potential carry-over effects. The gas was administered through an oro-nasal face mask with the inhalation order (i.e. CO~2~ versus air first) counterbalanced across participants in a within-subjects, single blind, cross-over design.

Measures of subjective state anxiety ([@bibr47-0269881114532858]), positive and negative affect ([@bibr52-0269881114532858]), and blood pressure (Omron-M6 arm-collar, Medisave, UK) were taken at the pre-test baseline (10 minutes before the first inhalation) and immediately (within 1 minute) after each inhalation period. Subjective ratings reflected the 'peak effects' of each inhalation. HR was measured at baseline (via the arm-collar) and recorded throughout each 20-minute inhalation from two electrodes placed on both wrists. An electrocardiogram (ECG) was recorded at 1000 Hz with a MP150 amplifier and AcqKnowledge 4.1 software (Biopac, CA, USA).

Startle task {#section6-0269881114532858}
------------

The startle task took 8 minutes to complete and was administered 2 minutes after each 20-minute inhalation period began. Participants were instructed that they would see a series of pictures and hear occasional noises. Participants viewed 32 images (16 aversive and 16 neutral) taken from the International Affective Picture Set (IAPS) ([@bibr31-0269881114532858]). The images were selected on the basis of normative valence (on a scale of −4 to +4) and image arousal ratings (0--8; for aversive images the mean valence was −3.85 and the mean arousal was 6.74; for neutral images, the mean valence was 2.30 and the mean arousal was 4.24). Images subtended 22.2 × 15.1 visual degrees (viewed at 58 cm distance) and were presented using Inquisit 2 ([Millisecond.com](http://Millisecond.com), 2002).

Startle reflexes were elicited with a 50ms, 96dB burst of white noise with a near instantaneous rise/fall time, delivered via headphones. A familiarisation block of 3 habituation startle probes was followed by an experimental block comprising 32 randomly ordered trials (24 experimental picture startle trials, 4 inter-trial interval (ITI) startle trials and 4 no-startle trials). On the experimental trials, aversive and neutral images were presented for 4000ms. The startle probe was presented 3000ms after the image onset. Interspersed within the experimental trials were four no-startle trials where the startle probe was omitted, and four trials where the startle probe was presented 7000ms after picture offset during a 14-second ITI. Both ITI- and no-startle trials were included to reduce the predictability of the startle probe. Picture valence was counterbalanced across trial type.

Eye-blink electromyography (EMG) data were recorded using two 4 mm electrodes placed under the centre and the outer canthus of the right eye. EMG was sampled at 1000 Hz, amplified by 10,000, rectified, filtered (30--500 Hz) and integrated (20 ms constant) using a Biopac MP150 data acquisition system and AcqKnowledge 4.1 software. Skin conductance responses to images were also recorded with silver/silver chloride (Ag-AgCl) electrodes and conductive gel attached to the medial phalanges of the ring and middle fingers of the participant's non-dominant hand.

Following the startle task, participants completed a 7-minute behavioural measure of impulse-control; see the stop-signal reaction time (SSRT) task. In this task, each participant's SSRT is estimated from a staircase analysis of their reaction-time distribution. For several participants, the algorithm was unable to converge on a reliable estimate of SSRT for both inhalations, perhaps reflecting an insufficient number of trials in our version of the task. Thus, reliable SSRT data was not available for this report.

Data preparation {#section7-0269881114532858}
----------------

### Startle magnitude and latency {#section8-0269881114532858}

Data from four participants were excluded from all startle analyses: three due to a technical fault (recording failure) and one who did not complete the task in full. Inspection of boxplots revealed startle responses that occurred \< 50 ms as extreme outliers. This equated to 3.3% of the experimental trials and these data were removed from both the magnitude and latency analyses. Startle magnitude was defined as the maximum response between 50--120ms after probe onset minus the mean EMG activity during the 50ms prior to probe onset. To correct for inter-subject variability, all blink magnitudes were standardised to T-scores (i.e. ((*z* × 10) +50)) within each participant using the condition mean and SD, which is a common procedure ([@bibr4-0269881114532858]). Startle latencies were reported relative to probe onset.

### Skin conductance {#section9-0269881114532858}

Skin conductance responses (SCRs) to the pictures were calculated by subtracting the mean skin conductance level 1000ms before picture onset (pre-trial baseline SCR) from the maximum skin conductance level between the 900--4000ms window after picture onset (peak SCR); this window excluded SCR responses to the acoustic startle probes.

### Heart rate {#section10-0269881114532858}

ECGs were band pass filtered (0.5--35 Hz) and QRS-template matched using AcqKnowledge 4.1 software.

Results {#section11-0269881114532858}
=======

Effects of 7.5% CO~2~ inhalation on subjective mood and cardiovascular function {#section12-0269881114532858}
-------------------------------------------------------------------------------

Inhalation of 7.5% CO~2~ significantly increased state anxiety and HR, and decreased positive affect ([Table 1](#table1-0269881114532858){ref-type="table"}). Systolic and diastolic blood pressure were elevated during both CO~2~ and air inhalation, relative to baseline (see [Table 1](#table1-0269881114532858){ref-type="table"}).

###### 

Effects of 20-minute 7.5% CO~2~ challenge on anxiety, mood and autonomic arousal.

![](10.1177_0269881114532858-table1)

                    Baseline    Air       7.5% CO~2~   ANOVA                                          
  ----------------- ----------- --------- ------------ --------- ----------- --------- ------- ------ ------
  State anxiety     30.88^a^    (9.27)    33.75^a^     (8.72)    39.83^b^    (10.40)   15.87   .001   .379
  Positive affect   30.00^a^    (7.91)    28.46        (7.80)    25.78^b^    (7.45)    7.69    .001   .228
  Negative affect   12.26       (3.58)    12.48        (3.66)    13.63       (5.10)    2.36    .133   .079
  Systolic BP       117.52^a^   (13.43)   124.60^b^    (17.95)   131.28^b^   (22.30)   14.00   .001   .368
  Diastolic BP      70.60^a^    (7.42)    75.52^b^     (7.26)    75.76^b^    (12.12)   7.15    .005   .230
  Heart Rate        71.92^a^    (11.09)   72.99^a^     (9.70)    78.43^b^    (12.65)   10.63   .001   .316

Within each variable (row), the values with different superscripts are significantly different from each other: *p* \< .017 (Bonferroni correction applied).

ANOVA: analysis of variance; BP: blood pressure; CO2: carbon dioxide; M: mean; SD: standard deviation; N~p~^2^: partial eta squared; F: test statistic for analysis of variance.

Effect of 7.5% CO~2~ on startle and skin conductance responses {#section13-0269881114532858}
--------------------------------------------------------------

Within each dependent measure, repeated measures analyses of variance (ANOVA) examined the effects of inhalation (7.5% CO~2~ versus air), picture valence (aversive versus neutral) and their interaction, on startle magnitude, startle latency and skin conductance response (see [Table 2](#table2-0269881114532858){ref-type="table"} for descriptive statistics). There were no significant effects on startle magnitude (*F*'s \< .274; *p*'s \> .61). Startle latency was significantly slower during the inhalation of 7.5% CO~2~ relative to air, where *F* (1, 22) = 5.38; *p* = .030; η~p~^2^ = .196 (*M* = 102.22; *SE =* 0.95 and *M* = 100.71; *SE =* 0.92, respectively). Skin conductance responses were significantly greater during inhalation of 7.5% CO~2~ (*M* = .085; *SE* = .019) than air (*M* = .024; *SE* = .012; *F* (1, 25) = 8.85; *p* = .006; η~p~^2^ = .261). All other results were non-significant.

###### 

The untransformed mean (SD) of startle magnitude, startle latency and skin conductance responses during inhalation of air and CO~2~.

![](10.1177_0269881114532858-table2)

                           Air      7.5% CO~2~            
  ------------------------ -------- ------------ -------- ---------
  Startle magnitude (μV)   17.40    (17.70)      17.21    (16.16)
   Negative                17.55    (17.56)      17.37    (17.05)
   Neutral                 17.25    (18.14)      17.04    (15.55)
  Startle latency (ms)     100.71   (4.42)       102.22   (4.55)
   Negative                100.58   (4.53)       101.75   (5.19)
   Neutral                 100.83   (4.70)       102.68   (4.16)
  Skin conductance (μS)    .0242    (0.06)       .0848    (0.10)
   Negative                .0343    (0.11)       .0941    (0.13)
   Neutral                 .0141    (0.06)       .0756    (0.09)

CO~2~: carbon dioxide; M: mean; SD: standard deviation; uV: startle magnitude; ms: milliseconds; uS: microsiemens.

Associations between subjective and physiological responses to CO~2~ inhalation {#section14-0269881114532858}
-------------------------------------------------------------------------------

Difference scores were calculated to reflect the degree of CO~2~-induced increases in:

i.  Subjective response;

ii. Autonomic response (HR and blood pressure);

iii. Magnitude and latency of startle response; and

iv. Skin conductance response.

There were positive associations between CO~2~-induced state anxiety, HR and blood pressure ([Table 3](#table3-0269881114532858){ref-type="table"}). The effect of CO~2~ on HR was strongly associated with reduced skin conductance responses during CO~2~ inhalation relative to air, and was also associated with slower startle latencies ([Figure 1](#fig1-0269881114532858){ref-type="fig"}). Furthermore, CO~2~-induced increases in negative affect correlated positively with increased anxiety and HR, whereas CO~2~-induced decreases in positive affect negatively correlated with increased anxiety and blood pressure. Finally, greater negative affect during CO~2~ inhalation was associated with larger startle responses during CO~2~ relative to air.

###### 

Pearson's R correlations between CO~2~-induced subjective and autonomic responses.

![](10.1177_0269881114532858-table3)

                             1\.                                                            2\.                                                            3\.                                                           4\.                                                           5\.                                                           6\.                                                            7\.     8\.    9\.
  -------------------------- -------------------------------------------------------------- -------------------------------------------------------------- ------------------------------------------------------------- ------------------------------------------------------------- ------------------------------------------------------------- -------------------------------------------------------------- ------- ------ -----
  State anxiety                                                                                                                                                                                                                                                                                                                                                                                                                    
  Positive affect            −.644^[c](#table-fn6-0269881114532858){ref-type="table-fn"}^                                                                                                                                                                                                                                                                                                                                          
  Negative affect            .771^[c](#table-fn6-0269881114532858){ref-type="table-fn"}^    −.319                                                                                                                                                                                                                                                                                                                                  
  Systolic blood pressure    .497^[a](#table-fn4-0269881114532858){ref-type="table-fn"}^    −.536^[b](#table-fn5-0269881114532858){ref-type="table-fn"}^   .267                                                                                                                                                                                                                                                                    
  Diastolic blood pressure   .433^[a](#table-fn4-0269881114532858){ref-type="table-fn"}^    −.370                                                          .199                                                          .575^[b](#table-fn5-0269881114532858){ref-type="table-fn"}^                                                                                                                                               
  Heart rate                 .461^[a](#table-fn4-0269881114532858){ref-type="table-fn"}^    −.313                                                          .424^[a](#table-fn4-0269881114532858){ref-type="table-fn"}^   .499^[a](#table-fn4-0269881114532858){ref-type="table-fn"}^   .535^[b](#table-fn5-0269881114532858){ref-type="table-fn"}^                                                                                 
  Startle magnitude          .040                                                           .262                                                           .414^[a](#table-fn4-0269881114532858){ref-type="table-fn"}^   −.232                                                         −.241                                                         .179                                                                          
  Startle latency            .093                                                           −.061                                                          .153                                                          −.082                                                         −.283                                                         .506^[a](#table-fn4-0269881114532858){ref-type="table-fn"}^    .126           
  Skin conductance           −.079                                                          −.050                                                          −.116                                                         −.206                                                         −.159                                                         −.452^[a](#table-fn4-0269881114532858){ref-type="table-fn"}^   −.171   .022   

Significant at \< .05

Significant at \< .01

Significant at \< .001

CO~2~: carbon dioxide

![Association between CO~2~-induced increases in heart rate and startle latency.\
CO~2~: carbon dioxide](10.1177_0269881114532858-fig1){#fig1-0269881114532858}

Discussion {#section15-0269881114532858}
==========

The defensive startle response is characterised by a rapid and powerful eye-blink that is potentiated by the extended amygdala. We examined the effects of CO~2~ challenge on both the magnitude and latency of startle responses. Contrary to predictions, 7.5% CO~2~ inhalation did not modulate eye-blink magnitude. Rather, it slowed the latency of eye-blink responses to startle probes. These findings extend previous evidence that inhalation of 7.5% CO~2~ for short periods (\<2 minutes) can reduce (rather than potentiate) the magnitude of startle responses to probes that are delivered in the absence of emotional stimuli ([@bibr6-0269881114532858]; [@bibr39-0269881114532858]).

Why might 7.5% CO~2~ challenge delay eye-blink startle latencies (present study) and/or reduce their magnitude ([@bibr6-0269881114532858]; [@bibr39-0269881114532858])? One possibility is that CO~2~ challenge may limit the processing resources required for a defensive startle. Consistent with previous findings, CO~2~ challenge produced large increases in subjective anxiety and autonomic arousal, including HR and skin conductance. Furthermore, CO~2~-induced increases in HR covaried with both subjective anxiety and longer startle latency during CO~2~ challenge. Strong positive correlations between CO~2~-increased HR and subjective anxiety were reported in previous studies ([@bibr17-0269881114532858], [@bibr18-0269881114532858]), and likely reflect participants' use of interoceptive 'threat' when rating their subjective anxiety. Notably, attenuated startle responses are observed in paradigms that directly target interoceptive mechanisms (e.g. pain caused by cold pressor or mechanically resisted breathing; [@bibr6-0269881114532858], [@bibr40-0269881114532858]). Startle responses are also attenuated when cognitive load is high (e.g. through increased task demand; see [@bibr51-0269881114532858]). Recent comparisons of 7.5% CO~2~ challenge and cognitive load suggest that both manipulations might produce comparable deficits in behaviour through common effects on top-down attention/control mechanisms ([@bibr35-0269881114532858]). Thus, CO~2~-induced deficits in cognitive control, together with increased awareness of competing interoceptive threat cues and corresponding increases in cognitive load, may limit the resources required to potentiate startle, thus slowing startle responses and obscuring the typical effects of picture valence on startle magnitude (such as [@bibr50-0269881114532858]).

How do our findings fit with those from eye-blink startle studies in other forms of anxiety? Potentiated startle is reliably demonstrated in PTSD (e.g. [@bibr37-0269881114532858]), specific phobias (e.g. [@bibr27-0269881114532858]), social anxiety (e.g. [@bibr9-0269881114532858]; [@bibr17-0269881114532858]) and panic disorder (e.g. [@bibr25-0269881114532858]). In contrast, there is comparatively weak evidence of potentiated startle in generalised anxiety disorder (GAD; as seen in a review by [@bibr49-0269881114532858]), and even evidence of reduced startle reactivity during anticipation of uncertain threat in GAD relative to other anxiety subtypes ([@bibr26-0269881114532858]; see [@bibr34-0269881114532858]), which may be due to its high comorbidity with depression where blunted startles are also a common feature ([@bibr48-0269881114532858]).

A 7.5% CO~2~ challenge in healthy volunteers has been proposed as an experimental model of GAD ([@bibr1-0269881114532858], [@bibr2-0269881114532858]). Drug treatments that are clinically effective for generalised anxiety can reduce some of the deleterious effects of 7.5% CO~2~ challenge and support the GAD model ([@bibr12-0269881114532858]). Likewise, we have recently shown that 7.5% CO~2~ challenge can mimic the deficits in attention control that are observed in unchallenged individuals with elevated generalised trait anxiety ([@bibr16-0269881114532858]). Consequently, the unexpected effects of 7.5% CO~2~ on startle that are reported here appear to be consistent with patterns of startle responding that are observed in conditions associated with broad negative affect, rather than acute periods of fear and panic ([@bibr34-0269881114532858]).

Converging evidence implicates the extended amygdala in potentiating startle responses ([@bibr41-0269881114532858]) and mediating CO~2~-induced behaviour in animals ([@bibr54-0269881114532858]). However, our findings and those of [@bibr39-0269881114532858] and [@bibr6-0269881114532858] suggest that subjective and autonomic response to CO~2~ challenge can occur in the absence of defensive behaviour coordinated by the amygdala. New evidence that individuals with bilateral amygdala lesions can display strong subjective and autonomic responses to 35% CO~2~ challenge suggests that mechanisms beyond the amygdala may mediate the human response to CO~2~ challenge ([@bibr14-0269881114532858]). [@bibr13-0269881114532858] propose a distributed network of brain regions that underlie CO~2~ challenge, including the locus coeruleus, hypothalamus, midbrain raphe and amygdala. Future research should clarify the neuro-pharmacological networks and peripheral chemoreceptor and mechanoreceptor systems that underlie the subjective, autonomic and behavioural responses to CO~2~ challenge in humans, and the factors that predict individual differences in response to challenge. To this end, research should examine whether anxiolytic drugs that modulate startle during anxious uncertainty but not phasic fear (e.g. the benzodiazepine alprazolam; [@bibr21-0269881114532858]; [@bibr23-0269881114532858]) can also reduce the effects of CO~2~ challenge on anxiety, autonomic arousal and startle reactivity. Furthermore, studies should take continuous measures of subjective mood (in addition to peak subjective effects), blood pressure, HR and respiration rate/volume (which was not measured here), to help dissociate phasic and sustained responses throughout CO~2~ challenge. This would extend initial evidence that suggests that the autonomic effects of 7.5% CO~2~ might rise early in the inhalation period and continue to increase gradually across the 20 minutes ([@bibr1-0269881114532858]; [@bibr42-0269881114532858]), and that the effect of CO~2~ on HR in our study was greater during the latter stages of the inhalation (mean HR between 15--20 min of CO~2~ = 81bpm, versus a mean HR between 5--10 min of CO~2~ = 76bpm; *p* = .021; *d* = .88).

Our findings and those of [@bibr39-0269881114532858] and [@bibr6-0269881114532858] suggest that 7.5% CO~2~ challenge inhibits eye-blink startle. However these three studies differ markedly in design (within versus between subjects), inhalation duration (ranging from \< 2 minutes to 20 minutes), number of startles, and affective paradigm (contextual versus emotional picture-potentiated). Our startle paradigm is based on those widely used in previous emotional picture-potentiated startle studies such as by [@bibr50-0269881114532858], however it has not been widely used in within-subject designs, and it is possible that in our study habituation to aversive stimuli may increase the likelihood of Type II error. Future research in this area will benefit from the recent development of standardized startle protocols that have already shown promise in validation studies, and which can differentiate startle responses during phasic cued fear versus sustained contextual anxiety (e.g. the NPU threat test, a standardized protocol consisting of a neutral (N) condition, an aversive condition where the threat is predictable (P) and an aversive condition where the threat is unpredictable (U); see [@bibr44-0269881114532858]). For example, evidence that the effects of 7.5% CO~2~ challenge on startle mimic anxiety-potentiated, rather than fear-potentiated startle in the NPU-threat test would further validate 7.5% CO~2~ as a model of anxiety.

In sum, despite strong effects of 7.5% CO~2~ challenge on subjective anxiety and autonomic arousal, we did not find evidence that CO~2~ challenge potentiates defensive startle behaviour. Instead, findings to date have suggested that 7.5% CO~2~ reduces the speed and magnitude of startle responses, consistent with startle profiles observed during interoceptive threat, increased cognitive load, and in populations characterised by anxiety and depression rather than acute fear and panic.
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